InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,016.00
(
-0.10%
)
Post# of 403586
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

farrell90

Send PM Follow Ignore
Followers 134
Posts 3756
Boards Moderated 0
Alias Born 01/28/2006

farrell90

Member Level

Re: Blue Fin post# 350877

Saturday, 03/06/2021 7:00:10 PM

Saturday, March 06, 2021 7:00:10 PM

Post# of 403586
Ridgeback Biotherapeutics has an interesting as well as colorful history in its efforts to profit from Molnupiravir :

https://www.washingtonpost.com/business/2020/06/11/coronavirus-drug-
ridgeback-biotherapeutics/

https://pulitzercenter.org/stories/emails-offer-look-whistleblower-charges-cronyism-behind-potential-covid-19-drug

Molnupiravir is an oral drug with a mechanism of action similar to Remedesivir and Favipiravir. The phase 1 study is linked below:

https://aac.asm.org/content/aac/early/2021/02/24/AAC.02428-20.full.pdf

Interesting the hedge fund manager,Wayne Holman, is listed as a lead author of the Phase1 report.

Glta,Farrell
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!